The objective of this clinical trial is to document the steady state pharmacokinetics and safety of a new itraconazole 200 mg film coated tablet.
Study Type
INTERVENTIONAL
Allocation
NA
Masking
NONE
Enrollment
16
Oral
Advanced Biomedical Research
Hackensack, New Jersey, United States
Steady State Plasma levels of Itraconazole
Time frame: 2 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.